BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 185 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $32,535,871 | +46.2% | 301,873 | +28.7% | 0.01% | +12.5% |
Q1 2024 | $22,255,580 | +0.9% | 234,615 | -1.9% | 0.01% | -11.1% |
Q4 2023 | $22,061,316 | +81.4% | 239,173 | -1.2% | 0.01% | +80.0% |
Q3 2023 | $12,162,882 | +7.1% | 242,192 | -4.0% | 0.01% | 0.0% |
Q2 2023 | $11,353,181 | 0.0% | 252,349 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $11,353,181 | -1.0% | 252,349 | -3.6% | 0.01% | -16.7% |
Q4 2022 | $11,464,419 | -99.9% | 261,685 | -2.5% | 0.01% | -40.0% |
Q3 2022 | $17,689,817,000 | +24.9% | 268,475 | -4.2% | 0.01% | +42.9% |
Q2 2022 | $14,161,084,000 | -7.6% | 280,362 | +16.8% | 0.01% | 0.0% |
Q1 2022 | $15,329,667,000 | -39.0% | 239,976 | +2.3% | 0.01% | -30.0% |
Q4 2021 | $25,128,757,000 | -6.4% | 234,607 | -10.1% | 0.01% | -9.1% |
Q3 2021 | $26,841,739,000 | +8.1% | 261,081 | -7.5% | 0.01% | 0.0% |
Q2 2021 | $24,837,177,000 | -1.1% | 282,369 | +9.4% | 0.01% | 0.0% |
Q1 2021 | $25,101,384,000 | -33.8% | 258,165 | -23.6% | 0.01% | -38.9% |
Q4 2020 | $37,906,925,000 | +35.9% | 338,002 | +12.3% | 0.02% | +20.0% |
Q3 2020 | $27,899,178,000 | +28.1% | 300,962 | +7.8% | 0.02% | +15.4% |
Q2 2020 | $21,778,536,000 | +304.0% | 279,212 | +202.9% | 0.01% | +225.0% |
Q1 2020 | $5,390,277,000 | -51.2% | 92,173 | -33.1% | 0.00% | -42.9% |
Q4 2019 | $11,043,323,000 | +10.6% | 137,852 | +1.4% | 0.01% | 0.0% |
Q3 2019 | $9,987,659,000 | -19.9% | 135,942 | +2.9% | 0.01% | -22.2% |
Q2 2019 | $12,461,747,000 | +19.6% | 132,108 | +1.5% | 0.01% | +12.5% |
Q1 2019 | $10,418,907,000 | +53.7% | 130,155 | +3.5% | 0.01% | +33.3% |
Q4 2018 | $6,778,429,000 | -35.0% | 125,736 | -5.9% | 0.01% | -25.0% |
Q3 2018 | $10,430,299,000 | +29.5% | 133,619 | +5.3% | 0.01% | +33.3% |
Q2 2018 | $8,054,343,000 | -18.7% | 126,880 | +17.5% | 0.01% | -25.0% |
Q1 2018 | $9,903,967,000 | +19.6% | 108,004 | -1.6% | 0.01% | +14.3% |
Q4 2017 | $8,279,113,000 | +9.4% | 109,788 | +1.0% | 0.01% | 0.0% |
Q3 2017 | $7,570,551,000 | +1044.8% | 108,663 | +732.6% | 0.01% | +600.0% |
Q2 2017 | $661,294,000 | +229.7% | 13,051 | +160.2% | 0.00% | – |
Q1 2017 | $200,550,000 | +61230.3% | 5,015 | -54.5% | 0.00% | – |
Q3 2016 | $327,000 | +59.5% | 11,015 | +9.1% | 0.00% | – |
Q2 2016 | $205,000 | +12.6% | 10,100 | 0.0% | 0.00% | – |
Q1 2016 | $182,000 | -94.4% | 10,100 | -91.9% | 0.00% | -100.0% |
Q4 2015 | $3,278,000 | +13.9% | 124,431 | -7.8% | 0.00% | +33.3% |
Q3 2015 | $2,879,000 | -8.9% | 134,921 | +13.1% | 0.00% | 0.0% |
Q2 2015 | $3,160,000 | – | 119,279 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |